Health and health care; personal characteristics
| Characteristics | Margins | Periods | Chronic disorders 1 or more chronic disorders (%) | Chronic disorders Disorders survey date/last 12 months Stroke, 12 years or older (%) | Chronic disorders Disorders survey date/last 12 months Myocardial infarction, 12 y or older (%) | Chronic disorders Disorders survey date/last 12 months Heart condition, 12 years or older (%) | Chronic disorders Disorders survey date/last 12 months Cancer (%) | Chronic disorders Disorders survey date/last 12 months Migraine or serious headache (%) | Chronic disorders Disorders survey date/last 12 months Asthma (%) | Chronic disorders Disorders survey date/last 12 months COPD, chronic bronch., pulm. emphysema (%) | Chronic disorders Disorders survey date/last 12 months Abdominal disorders longer than 3 mont (%) | Chronic disorders Disorders survey date/last 12 months Chronic arthritis (%) | Chronic disorders Disorders survey date/last 12 months Spinal disorder (%) | Chronic disorders Disorders survey date/last 12 months Disorder back of the neck or shoulder (%) | Chronic disorders Disorders survey date/last 12 months Allergy (%) | Chronic disorders Disorders survey date/last 12 months Hypertension, 12 plus (%) | Chronic disorders Disorders survey date/last 12 months Non-voluntary urine loss, 12 plus (%) | Chronic disorders Disorders survey date/last 12 months Arthrosis hips /knees, 12 plus (%) | Chronic disorders Disorders survey date/last 12 months Cirrhosis of liver, 12 plus (%) | Chronic disorders Disorders survey date/last 12 months Kidney disorder, 12 plus (%) | Chronic disorders Disorders survey date/last 12 months Depression, 12 plus (%) | Chronic disorders Disorders survey date/last 12 months ADHD or ADD, 4 plus (%) | Chronic disorders Disorders survey date/last 12 months Autism spectrum disorder, 4 plus (%) | Chronic disorders Disorders survey date/last 12 months Other disorders/diseases (%) | Chronic disorders Chronic disorders, ever had Stroke, 12 plus (%) | Chronic disorders Chronic disorders, ever had Myocardial infarction, 12 plus (%) | Chronic disorders Chronic disorders, ever had Cancer (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total persons | Value | 2023 | 31.2 | 0.5 | 0.3 | 2.5 | 2.8 | 14.3 | 6.3 | 4.0 | 4.7 | 6.9 | 8.1 | 7.4 | 21.1 | 15.2 | 7.4 | 15.9 | . | . | 9.4 | 4.9 | 2.4 | 13.3 | 3.0 | 2.8 | 8.1 |
| Total persons | Lower bound 95% confidence interval | 2023 | 30.3 | 0.4 | 0.2 | 2.2 | 2.5 | 13.6 | 5.8 | 3.6 | 4.3 | 6.4 | 7.5 | 6.9 | 20.3 | 14.4 | 6.9 | 15.1 | . | . | 8.7 | 4.4 | 2.1 | 12.6 | 2.7 | 2.5 | 7.6 |
| Total persons | Upper bound 95% confidence interval | 2023 | 32.2 | 0.7 | 0.5 | 2.8 | 3.2 | 15.1 | 6.9 | 4.4 | 5.2 | 7.5 | 8.7 | 8.0 | 22.0 | 16.0 | 8.0 | 16.7 | . | . | 10.1 | 5.4 | 2.7 | 14.0 | 3.4 | 3.2 | 8.7 |
| Sex: Male | Value | 2023 | 28.9 | 0.6 | 0.4 | 2.8 | 2.7 | 9.4 | 6.1 | 3.8 | 3.4 | 4.5 | 7.9 | 5.9 | 19.9 | 14.3 | 3.0 | 13.0 | . | . | 8.3 | 5.9 | 3.1 | 11.3 | 3.4 | 3.9 | 6.8 |
| Sex: Male | Lower bound 95% confidence interval | 2023 | 27.6 | 0.4 | 0.3 | 2.4 | 2.3 | 8.5 | 5.4 | 3.3 | 2.9 | 4.0 | 7.2 | 5.2 | 18.7 | 13.3 | 2.5 | 12.1 | . | . | 7.4 | 5.2 | 2.6 | 10.4 | 2.8 | 3.3 | 6.1 |
| Sex: Male | Upper bound 95% confidence interval | 2023 | 30.3 | 0.9 | 0.7 | 3.4 | 3.1 | 10.3 | 6.9 | 4.4 | 4.0 | 5.2 | 8.8 | 6.6 | 21.1 | 15.5 | 3.6 | 14.1 | . | . | 9.3 | 6.7 | 3.7 | 12.3 | 3.9 | 4.5 | 7.5 |
| Sex: Female | Value | 2023 | 33.5 | 0.5 | 0.2 | 2.1 | 3.0 | 19.2 | 6.6 | 4.2 | 6.0 | 9.3 | 8.3 | 9.0 | 22.4 | 16.0 | 11.7 | 18.6 | . | . | 10.4 | 3.9 | 1.6 | 15.2 | 2.7 | 1.8 | 9.5 |
| Sex: Female | Lower bound 95% confidence interval | 2023 | 32.2 | 0.3 | 0.1 | 1.7 | 2.6 | 18.1 | 5.9 | 3.7 | 5.3 | 8.5 | 7.5 | 8.2 | 21.2 | 14.9 | 10.8 | 17.5 | . | . | 9.5 | 3.4 | 1.3 | 14.2 | 2.3 | 1.4 | 8.7 |
| Sex: Female | Upper bound 95% confidence interval | 2023 | 34.9 | 0.7 | 0.4 | 2.6 | 3.5 | 20.4 | 7.3 | 4.8 | 6.7 | 10.2 | 9.1 | 9.9 | 23.7 | 17.1 | 12.7 | 19.9 | . | . | 11.5 | 4.6 | 2.0 | 16.3 | 3.2 | 2.3 | 10.3 |
| Age: 0 to 3 years | Value | 2023 | 6.4 | . | . | . | 0.0 | 0.6 | 2.2 | 0.2 | 1.1 | 0.0 | 0.0 | 0.3 | 7.4 | . | . | . | . | . | . | . | . | 6.1 | . | . | 0.0 |
| Age: 0 to 3 years | Lower bound 95% confidence interval | 2023 | 4.3 | . | . | . | 0.0 | 0.1 | 1.1 | 0.0 | 0.4 | 0.0 | 0.0 | 0.0 | 5.0 | . | . | . | . | . | . | . | . | 4.1 | . | . | 0.0 |
| Age: 0 to 3 years | Upper bound 95% confidence interval | 2023 | 9.5 | . | . | . | . | 2.2 | 4.4 | 1.7 | 2.9 | . | . | 2.2 | 10.7 | . | . | . | . | . | . | . | . | 9.2 | . | . | . |
| Age: 4 to 11 years | Value | 2023 | 11.3 | . | . | . | 0.2 | 4.6 | 5.3 | 1.8 | 2.1 | 0.0 | 0.4 | 0.0 | 14.9 | . | . | . | . | . | . | 5.1 | 3.2 | 7.9 | . | . | 0.2 |
| Age: 4 to 11 years | Lower bound 95% confidence interval | 2023 | 9.2 | . | . | . | 0.0 | 3.3 | 3.8 | 1.0 | 1.2 | 0.0 | 0.1 | 0.0 | 12.6 | . | . | . | . | . | . | 3.7 | 2.2 | 6.2 | . | . | 0.0 |
| Age: 4 to 11 years | Upper bound 95% confidence interval | 2023 | 13.7 | . | . | . | 1.4 | 6.4 | 7.1 | 3.0 | 3.4 | . | 1.1 | . | 17.7 | . | . | . | . | . | . | 6.9 | 4.9 | 10.0 | . | . | 1.4 |
| Age: 12 to 15 years | Value | 2023 | 10.9 | 0.0 | 0.2 | 0.4 | 0.2 | 10.8 | 5.9 | 0.9 | 2.3 | 0.8 | 0.7 | 0.8 | 22.2 | 0.9 | 1.0 | 1.2 | . | . | 4.2 | 10.3 | 4.4 | 3.3 | 0.0 | 0.2 | 0.5 |
| Age: 12 to 15 years | Lower bound 95% confidence interval | 2023 | 8.3 | 0.0 | 0.0 | 0.1 | 0.0 | 8.3 | 4.1 | 0.3 | 1.2 | 0.3 | 0.2 | 0.3 | 18.7 | 0.3 | 0.4 | 0.5 | . | . | 2.7 | 7.8 | 2.9 | 2.0 | 0.0 | 0.0 | 0.1 |
| Age: 12 to 15 years | Upper bound 95% confidence interval | 2023 | 14.1 | . | 1.6 | 1.7 | 1.6 | 14.0 | 8.5 | 2.3 | 4.2 | 2.2 | 2.0 | 2.0 | 26.3 | 2.4 | 2.5 | 2.8 | . | . | 6.5 | 13.3 | 6.7 | 5.3 | . | 1.6 | 1.8 |
| Age: 16 to 19 years | Value | 2023 | 14.1 | 0.0 | 0.0 | 0.2 | 0.0 | 18.1 | 7.6 | 0.9 | 2.4 | 1.0 | 3.5 | 2.2 | 30.6 | 3.4 | 0.7 | 0.2 | . | . | 12.2 | 8.6 | 4.9 | 7.9 | 0.0 | 0.0 | 0.5 |
| Age: 16 to 19 years | Lower bound 95% confidence interval | 2023 | 11.0 | 0.0 | 0.0 | 0.0 | 0.0 | 14.6 | 5.4 | 0.3 | 1.2 | 0.4 | 2.1 | 1.2 | 26.3 | 2.0 | 0.2 | 0.0 | . | . | 9.4 | 6.2 | 3.2 | 5.6 | 0.0 | 0.0 | 0.1 |
| Age: 16 to 19 years | Upper bound 95% confidence interval | 2023 | 17.8 | . | . | 1.6 | . | 22.1 | 10.6 | 2.4 | 4.6 | 2.7 | 5.8 | 4.3 | 35.2 | 5.7 | 2.2 | 1.5 | . | . | 15.7 | 11.7 | 7.4 | 11.0 | . | . | 1.9 |
| Age: 20 to 29 years | Value | 2023 | 21.8 | 0.2 | 0.0 | 0.5 | 0.1 | 19.9 | 8.0 | 1.1 | 3.6 | 2.0 | 3.7 | 3.6 | 27.1 | 2.5 | 2.2 | 1.6 | . | . | 12.4 | 10.3 | 4.8 | 12.5 | 0.4 | 0.1 | 0.3 |
| Age: 20 to 29 years | Lower bound 95% confidence interval | 2023 | 19.3 | 0.0 | 0.0 | 0.2 | 0.0 | 17.5 | 6.5 | 0.6 | 2.6 | 1.3 | 2.7 | 2.6 | 24.4 | 1.6 | 1.5 | 1.0 | . | . | 10.4 | 8.5 | 3.6 | 10.5 | 0.2 | 0.0 | 0.1 |
| Age: 20 to 29 years | Upper bound 95% confidence interval | 2023 | 24.5 | 0.8 | . | 1.3 | 0.7 | 22.5 | 9.9 | 1.9 | 4.9 | 3.1 | 5.1 | 5.1 | 30.0 | 3.8 | 3.4 | 2.6 | . | . | 14.7 | 12.4 | 6.3 | 14.7 | 1.1 | 0.5 | 0.9 |
| Age: 30 to 39 years | Value | 2023 | 23.6 | 0.2 | 0.0 | 0.5 | 0.7 | 22.5 | 5.8 | 1.9 | 5.1 | 2.7 | 6.6 | 5.0 | 29.7 | 5.1 | 3.3 | 3.1 | . | . | 9.8 | 7.2 | 3.3 | 12.1 | 1.1 | 0.2 | 2.3 |
| Age: 30 to 39 years | Lower bound 95% confidence interval | 2023 | 21.1 | 0.0 | 0.0 | 0.2 | 0.4 | 20.0 | 4.5 | 1.2 | 3.9 | 1.8 | 5.3 | 3.8 | 27.0 | 3.8 | 2.4 | 2.2 | . | . | 8.1 | 5.8 | 2.3 | 10.3 | 0.6 | 0.1 | 1.6 |
| Age: 30 to 39 years | Upper bound 95% confidence interval | 2023 | 26.3 | 0.8 | . | 1.2 | 1.5 | 25.2 | 7.4 | 3.1 | 6.6 | 3.8 | 8.4 | 6.5 | 32.5 | 6.7 | 4.5 | 4.3 | . | . | 11.8 | 9.0 | 4.6 | 14.2 | 2.1 | 0.7 | 3.4 |
| Age: 40 to 49 years | Value | 2023 | 31.7 | 0.3 | 0.3 | 1.0 | 1.7 | 21.0 | 5.8 | 2.5 | 5.7 | 6.0 | 8.6 | 10.3 | 25.8 | 8.2 | 7.0 | 8.8 | . | . | 9.1 | 4.4 | 1.5 | 14.7 | 1.2 | 0.9 | 4.2 |
| Age: 40 to 49 years | Lower bound 95% confidence interval | 2023 | 28.8 | 0.1 | 0.1 | 0.5 | 1.1 | 18.5 | 4.5 | 1.7 | 4.4 | 4.6 | 6.9 | 8.5 | 23.1 | 6.5 | 5.6 | 7.1 | . | . | 7.4 | 3.2 | 0.9 | 12.6 | 0.7 | 0.4 | 3.2 |
| Age: 40 to 49 years | Upper bound 95% confidence interval | 2023 | 34.7 | 1.1 | 1.0 | 1.9 | 2.7 | 23.7 | 7.5 | 3.7 | 7.4 | 7.7 | 10.7 | 12.5 | 28.6 | 10.2 | 8.7 | 10.8 | . | . | 11.2 | 5.9 | 2.5 | 17.1 | 2.2 | 1.8 | 5.6 |
| Age: 50 to 54 years | Value | 2023 | 38.6 | 0.6 | 0.3 | 1.8 | 2.7 | 18.0 | 7.7 | 4.2 | 6.7 | 10.7 | 11.8 | 12.7 | 23.1 | 14.8 | 6.4 | 16.5 | . | . | 9.9 | 3.1 | 0.7 | 18.0 | 2.6 | 2.5 | 7.1 |
| Age: 50 to 54 years | Lower bound 95% confidence interval | 2023 | 34.8 | 0.2 | 0.1 | 1.0 | 1.7 | 15.1 | 5.8 | 2.9 | 4.9 | 8.4 | 9.4 | 10.2 | 19.8 | 12.2 | 4.7 | 13.8 | . | . | 7.7 | 1.9 | 0.3 | 15.1 | 1.5 | 1.4 | 5.3 |
| Age: 50 to 54 years | Upper bound 95% confidence interval | 2023 | 42.6 | 1.7 | 1.2 | 3.2 | 4.3 | 21.3 | 10.3 | 6.3 | 9.0 | 13.4 | 14.7 | 15.6 | 26.6 | 18.0 | 8.7 | 19.7 | . | . | 12.7 | 4.8 | 1.7 | 21.2 | 4.3 | 4.3 | 9.3 |
| Age: 55 to 64 years | Value | 2023 | 45.1 | 0.6 | 0.8 | 2.8 | 4.6 | 14.6 | 6.9 | 6.1 | 5.5 | 12.5 | 11.8 | 12.3 | 18.1 | 24.0 | 7.6 | 25.8 | . | . | 10.6 | 2.2 | 1.2 | 16.5 | 3.1 | 4.4 | 13.3 |
| Age: 55 to 64 years | Lower bound 95% confidence interval | 2023 | 42.3 | 0.3 | 0.4 | 2.0 | 3.6 | 12.7 | 5.6 | 4.9 | 4.3 | 10.7 | 10.0 | 10.5 | 16.0 | 21.7 | 6.2 | 23.5 | . | . | 8.9 | 1.5 | 0.7 | 14.6 | 2.3 | 3.4 | 11.5 |
| Age: 55 to 64 years | Upper bound 95% confidence interval | 2023 | 47.8 | 1.2 | 1.5 | 3.9 | 5.9 | 16.8 | 8.6 | 7.6 | 6.9 | 14.5 | 13.8 | 14.3 | 20.4 | 26.5 | 9.2 | 28.3 | . | . | 12.5 | 3.1 | 2.0 | 18.7 | 4.2 | 5.7 | 15.2 |
| Age: 65 to 74 years | Value | 2023 | 51.0 | 0.8 | 0.3 | 4.7 | 7.5 | 6.5 | 6.2 | 9.6 | 6.4 | 15.1 | 15.5 | 10.4 | 15.5 | 31.4 | 12.3 | 34.5 | . | . | 7.2 | 0.9 | 0.8 | 17.4 | 6.7 | 5.8 | 21.4 |
| Age: 65 to 74 years | Lower bound 95% confidence interval | 2023 | 48.1 | 0.4 | 0.1 | 3.7 | 6.1 | 5.2 | 4.9 | 8.0 | 5.1 | 13.1 | 13.5 | 8.8 | 13.5 | 28.9 | 10.6 | 31.9 | . | . | 5.8 | 0.5 | 0.4 | 15.3 | 5.4 | 4.6 | 19.1 |
| Age: 65 to 74 years | Upper bound 95% confidence interval | 2023 | 53.8 | 1.5 | 0.8 | 6.1 | 9.1 | 8.1 | 7.8 | 11.4 | 7.9 | 17.2 | 17.7 | 12.3 | 17.7 | 34.2 | 14.3 | 37.2 | . | . | 8.9 | 1.6 | 1.6 | 19.6 | 8.3 | 7.3 | 23.8 |
| Age: 75 years or older | Value | 2023 | 52.5 | 2.2 | 0.8 | 10.0 | 9.6 | 6.3 | 5.6 | 9.9 | 6.1 | 15.7 | 15.1 | 13.4 | 10.1 | 37.3 | 22.7 | 41.9 | . | . | 6.1 | 0.2 | 0.6 | 16.4 | 11.2 | 10.4 | 29.2 |
| Age: 75 years or older | Lower bound 95% confidence interval | 2023 | 49.3 | 1.4 | 0.4 | 8.3 | 7.9 | 4.9 | 4.3 | 8.1 | 4.8 | 13.5 | 13.0 | 11.4 | 8.3 | 34.3 | 20.2 | 38.8 | . | . | 4.7 | 0.0 | 0.3 | 14.2 | 9.4 | 8.6 | 26.4 |
| Age: 75 years or older | Upper bound 95% confidence interval | 2023 | 55.6 | 3.3 | 1.6 | 12.0 | 11.6 | 8.1 | 7.3 | 12.0 | 7.8 | 18.2 | 17.6 | 15.7 | 12.2 | 40.4 | 25.5 | 45.1 | . | . | 7.9 | 0.7 | 1.3 | 18.9 | 13.3 | 12.5 | 32.1 |
| Age: 0 to 11 years | Value | 2023 | 9.7 | . | . | . | 0.1 | 3.3 | 4.3 | 1.3 | 1.7 | 0.0 | 0.2 | 0.1 | 12.5 | . | . | . | . | . | . | 5.1 | 3.2 | 7.3 | . | . | 0.1 |
| Age: 0 to 11 years | Lower bound 95% confidence interval | 2023 | 8.1 | . | . | . | 0.0 | 2.4 | 3.2 | 0.7 | 1.1 | 0.0 | 0.1 | 0.0 | 10.6 | . | . | . | . | . | . | 3.7 | 2.2 | 5.9 | . | . | 0.0 |
| Age: 0 to 11 years | Upper bound 95% confidence interval | 2023 | 11.6 | . | . | . | 1.0 | 4.5 | 5.7 | 2.1 | 2.7 | . | 0.8 | 0.7 | 14.6 | . | . | . | . | . | . | 6.9 | 4.9 | 9.0 | . | . | 1.0 |
| Age: 12 to 17 years | Value | 2023 | 10.4 | 0.0 | 0.1 | 0.3 | 0.1 | 12.6 | 6.2 | 0.9 | 2.1 | 0.7 | 1.0 | 0.7 | 25.4 | 2.0 | 1.0 | 0.9 | . | . | 7.0 | 10.2 | 5.2 | 4.1 | 0.0 | 0.1 | 0.6 |
| Age: 12 to 17 years | Lower bound 95% confidence interval | 2023 | 8.3 | 0.0 | 0.0 | 0.1 | 0.0 | 10.3 | 4.6 | 0.4 | 1.2 | 0.3 | 0.5 | 0.3 | 22.3 | 1.2 | 0.5 | 0.4 | . | . | 5.3 | 8.1 | 3.8 | 2.9 | 0.0 | 0.0 | 0.2 |
| Age: 12 to 17 years | Upper bound 95% confidence interval | 2023 | 13.0 | . | 1.0 | 1.1 | 1.0 | 15.4 | 8.4 | 1.9 | 3.6 | 1.7 | 2.2 | 1.6 | 28.9 | 3.5 | 2.1 | 1.9 | . | . | 9.2 | 12.6 | 7.2 | 5.9 | . | 1.0 | 1.6 |
| Age: 18 years or older | Value | 2023 | 36.2 | 0.6 | 0.3 | 2.7 | 3.5 | 16.1 | 6.6 | 4.7 | 5.4 | 8.5 | 9.9 | 9.1 | 22.1 | 16.3 | 7.9 | 17.2 | . | . | 9.6 | 4.4 | 2.0 | 15.0 | 3.3 | 3.1 | 10.0 |
| Age: 18 years or older | Lower bound 95% confidence interval | 2023 | 35.1 | 0.4 | 0.2 | 2.3 | 3.1 | 15.3 | 6.1 | 4.2 | 4.9 | 7.9 | 9.2 | 8.5 | 21.1 | 15.5 | 7.4 | 16.3 | . | . | 8.9 | 3.9 | 1.7 | 14.2 | 2.9 | 2.7 | 9.4 |
| Age: 18 years or older | Upper bound 95% confidence interval | 2023 | 37.4 | 0.8 | 0.5 | 3.1 | 3.9 | 17.0 | 7.3 | 5.2 | 5.9 | 9.2 | 10.6 | 9.8 | 23.1 | 17.1 | 8.6 | 18.0 | . | . | 10.3 | 5.0 | 2.4 | 15.8 | 3.7 | 3.5 | 10.7 |
| The Netherlands | Value | 2023 | 31.7 | 0.6 | 0.3 | 2.7 | 3.1 | 13.0 | 5.9 | 4.2 | 4.9 | 7.1 | 7.8 | 6.9 | 19.5 | 15.3 | 8.0 | 16.9 | . | . | 8.3 | 5.4 | 2.7 | 13.7 | 3.3 | 2.9 | 9.1 |
| The Netherlands | Lower bound 95% confidence interval | 2023 | 30.6 | 0.4 | 0.2 | 2.4 | 2.7 | 12.2 | 5.4 | 3.8 | 4.4 | 6.5 | 7.2 | 6.3 | 18.6 | 14.4 | 7.4 | 16.0 | . | . | 7.6 | 4.8 | 2.3 | 12.9 | 2.9 | 2.5 | 8.5 |
| The Netherlands | Upper bound 95% confidence interval | 2023 | 32.8 | 0.8 | 0.5 | 3.1 | 3.5 | 13.8 | 6.5 | 4.7 | 5.4 | 7.7 | 8.4 | 7.5 | 20.5 | 16.2 | 8.7 | 17.8 | . | . | 9.0 | 6.0 | 3.2 | 14.5 | 3.7 | 3.3 | 9.8 |
| Europe (excluding the Netherlands) | Value | 2023 | 29.4 | 0.7 | 0.5 | 2.6 | 3.8 | 17.6 | 6.1 | 4.1 | 4.9 | 7.2 | 8.4 | 8.5 | 22.3 | 16.5 | 6.6 | 15.9 | . | . | 10.8 | 5.5 | 2.4 | 11.2 | 4.0 | 3.3 | 8.9 |
| Europe (excluding the Netherlands) | Lower bound 95% confidence interval | 2023 | 26.1 | 0.3 | 0.1 | 1.6 | 2.6 | 14.8 | 4.5 | 2.9 | 3.4 | 5.5 | 6.5 | 6.6 | 19.2 | 13.7 | 4.9 | 13.2 | . | . | 8.5 | 3.9 | 1.4 | 9.0 | 2.7 | 2.2 | 7.0 |
| Europe (excluding the Netherlands) | Upper bound 95% confidence interval | 2023 | 33.0 | 1.9 | 1.5 | 4.2 | 5.5 | 20.8 | 8.3 | 5.8 | 6.8 | 9.5 | 10.8 | 10.9 | 25.7 | 19.7 | 8.8 | 19.1 | . | . | 13.7 | 7.8 | 3.9 | 13.9 | 5.9 | 5.0 | 11.2 |
| Outside Europe | Value | 2023 | 30.2 | 0.3 | 0.3 | 1.5 | 1.4 | 18.0 | 8.0 | 3.1 | 4.0 | 6.3 | 9.3 | 9.1 | 27.0 | 14.1 | 5.3 | 11.9 | . | . | 13.2 | 2.7 | 1.0 | 12.6 | 1.7 | 2.4 | 4.1 |
| Outside Europe | Lower bound 95% confidence interval | 2023 | 27.7 | 0.1 | 0.1 | 0.9 | 0.9 | 15.9 | 6.6 | 2.2 | 3.1 | 5.1 | 7.7 | 7.6 | 24.6 | 12.1 | 4.0 | 10.1 | . | . | 11.2 | 1.9 | 0.6 | 10.8 | 1.1 | 1.6 | 3.2 |
| Outside Europe | Upper bound 95% confidence interval | 2023 | 32.8 | 0.9 | 0.9 | 2.5 | 2.2 | 20.3 | 9.7 | 4.2 | 5.3 | 7.8 | 11.1 | 10.9 | 29.5 | 16.3 | 6.8 | 14.0 | . | . | 15.4 | 3.7 | 1.7 | 14.5 | 2.6 | 3.4 | 5.2 |
| Origin: born in the Netherlands | Value | 2023 | 30.7 | 0.6 | 0.3 | 2.5 | 2.9 | 13.1 | 6.2 | 4.1 | 4.6 | 6.7 | 7.5 | 6.6 | 20.5 | 14.8 | 7.6 | 16.1 | . | . | 8.5 | 5.2 | 2.6 | 13.1 | 3.1 | 2.8 | 8.6 |
| Origin: born in the Netherlands | Lower bound 95% confidence interval | 2023 | 29.7 | 0.4 | 0.2 | 2.2 | 2.6 | 12.4 | 5.6 | 3.7 | 4.2 | 6.1 | 6.9 | 6.1 | 19.6 | 14.0 | 7.0 | 15.3 | . | . | 7.8 | 4.7 | 2.2 | 12.4 | 2.8 | 2.5 | 8.0 |
| Origin: born in the Netherlands | Upper bound 95% confidence interval | 2023 | 31.7 | 0.8 | 0.4 | 2.9 | 3.3 | 13.9 | 6.7 | 4.5 | 5.1 | 7.2 | 8.1 | 7.2 | 21.4 | 15.6 | 8.2 | 16.9 | . | . | 9.2 | 5.7 | 3.0 | 13.9 | 3.6 | 3.2 | 9.2 |
| Origin: born in NL, parents in NL | Value | 2023 | 31.7 | 0.6 | 0.3 | 2.7 | 3.1 | 13.0 | 5.9 | 4.2 | 4.9 | 7.1 | 7.8 | 6.9 | 19.5 | 15.3 | 8.0 | 16.9 | . | . | 8.3 | 5.4 | 2.7 | 13.7 | 3.3 | 2.9 | 9.1 |
| Origin: born in NL, parents in NL | Lower bound 95% confidence interval | 2023 | 30.6 | 0.4 | 0.2 | 2.4 | 2.7 | 12.2 | 5.4 | 3.8 | 4.4 | 6.5 | 7.2 | 6.3 | 18.6 | 14.4 | 7.4 | 16.0 | . | . | 7.6 | 4.8 | 2.3 | 12.9 | 2.9 | 2.5 | 8.5 |
| Origin: born in NL, parents in NL | Upper bound 95% confidence interval | 2023 | 32.8 | 0.8 | 0.5 | 3.1 | 3.5 | 13.8 | 6.5 | 4.7 | 5.4 | 7.7 | 8.4 | 7.5 | 20.5 | 16.2 | 8.7 | 17.8 | . | . | 9.0 | 6.0 | 3.2 | 14.5 | 3.7 | 3.3 | 9.8 |
| Origin: born in NL, parent(s) abroad | Value | 2023 | 25.2 | 0.3 | 0.2 | 1.4 | 2.0 | 13.7 | 7.6 | 3.2 | 3.0 | 4.4 | 6.0 | 5.3 | 25.9 | 11.8 | 5.0 | 11.0 | . | . | 9.9 | 4.1 | 1.7 | 9.9 | 2.3 | 2.3 | 5.8 |
| Origin: born in NL, parent(s) abroad | Lower bound 95% confidence interval | 2023 | 22.6 | 0.1 | 0.0 | 0.8 | 1.3 | 11.6 | 6.0 | 2.3 | 2.1 | 3.3 | 4.7 | 4.1 | 23.3 | 9.8 | 3.7 | 9.0 | . | . | 7.9 | 2.9 | 1.0 | 8.2 | 1.5 | 1.5 | 4.6 |
| Origin: born in NL, parent(s) abroad | Upper bound 95% confidence interval | 2023 | 27.9 | 1.1 | 0.7 | 2.5 | 3.0 | 16.1 | 9.4 | 4.5 | 4.3 | 5.8 | 7.7 | 6.9 | 28.8 | 14.2 | 6.7 | 13.3 | . | . | 12.3 | 5.7 | 2.7 | 12.0 | 3.6 | 3.5 | 7.3 |
| Origin: born in NL, parent(s) in Europe | Value | 2023 | 30.7 | 0.7 | 0.6 | 3.4 | 5.0 | 12.6 | 6.8 | 4.1 | 3.8 | 6.1 | 9.3 | 6.5 | 20.7 | 18.6 | 7.5 | 18.4 | . | . | 7.0 | 5.5 | 3.0 | 8.7 | 5.0 | 4.9 | 11.3 |
| Origin: born in NL, parent(s) in Europe | Lower bound 95% confidence interval | 2023 | 26.0 | 0.2 | 0.1 | 1.8 | 3.1 | 9.3 | 4.5 | 2.5 | 2.2 | 4.0 | 6.7 | 4.4 | 16.6 | 14.5 | 5.0 | 14.3 | . | . | 4.5 | 3.4 | 1.6 | 6.0 | 3.0 | 3.0 | 8.4 |
| Origin: born in NL, parent(s) in Europe | Upper bound 95% confidence interval | 2023 | 35.8 | 2.8 | 2.2 | 6.1 | 7.9 | 16.7 | 10.1 | 6.8 | 6.4 | 9.1 | 12.8 | 9.6 | 25.5 | 23.5 | 11.1 | 23.4 | . | . | 10.8 | 9.0 | 5.6 | 12.3 | 8.1 | 8.0 | 15.1 |
| Origin: born NL, parent(s) out. Europe | Value | 2023 | 22.7 | 0.2 | 0.0 | 0.5 | 0.6 | 14.2 | 7.9 | 2.8 | 2.7 | 3.6 | 4.5 | 4.8 | 28.3 | 8.6 | 3.8 | 7.5 | . | . | 11.2 | 3.4 | 1.0 | 10.5 | 1.1 | 1.1 | 3.3 |
| Origin: born NL, parent(s) out. Europe | Lower bound 95% confidence interval | 2023 | 19.6 | 0.0 | 0.0 | 0.1 | 0.2 | 11.7 | 6.0 | 1.8 | 1.7 | 2.5 | 3.1 | 3.4 | 24.9 | 6.5 | 2.4 | 5.6 | . | . | 8.7 | 2.2 | 0.5 | 8.3 | 0.5 | 0.5 | 2.3 |
| Origin: born NL, parent(s) out. Europe | Upper bound 95% confidence interval | 2023 | 26.0 | 1.2 | . | 2.1 | 1.5 | 17.2 | 10.3 | 4.3 | 4.2 | 5.3 | 6.5 | 6.7 | 31.9 | 11.3 | 5.8 | 10.1 | . | . | 14.4 | 5.3 | 2.2 | 13.1 | 2.5 | 2.3 | 4.8 |
| Origin: born abroad | Value | 2023 | 34.4 | 0.5 | 0.4 | 2.2 | 2.3 | 21.7 | 7.3 | 3.6 | 5.4 | 8.6 | 11.8 | 12.3 | 25.2 | 17.1 | 6.2 | 14.8 | . | . | 14.4 | 3.1 | 1.2 | 14.2 | 2.5 | 2.9 | 5.3 |
| Origin: born abroad | Lower bound 95% confidence interval | 2023 | 31.4 | 0.2 | 0.2 | 1.5 | 1.6 | 19.2 | 5.8 | 2.5 | 4.1 | 7.0 | 9.8 | 10.3 | 22.5 | 14.8 | 4.8 | 12.6 | . | . | 12.1 | 2.1 | 0.7 | 12.1 | 1.6 | 2.0 | 4.1 |
| Origin: born abroad | Upper bound 95% confidence interval | 2023 | 37.5 | 1.3 | 1.2 | 3.4 | 3.5 | 24.5 | 9.3 | 4.9 | 7.1 | 10.6 | 14.1 | 14.6 | 28.1 | 19.8 | 8.0 | 17.2 | . | . | 16.9 | 4.5 | 2.2 | 16.6 | 3.7 | 4.2 | 6.9 |
| Origin: born in Europe (excl. NL) | Value | 2023 | 28.2 | 0.7 | 0.4 | 2.1 | 2.6 | 22.4 | 5.5 | 4.1 | 5.9 | 8.3 | 7.6 | 10.3 | 23.7 | 14.8 | 5.8 | 14.0 | . | . | 13.8 | 5.5 | 1.8 | 13.7 | 3.3 | 2.0 | 6.6 |
| Origin: born in Europe (excl. NL) | Lower bound 95% confidence interval | 2023 | 23.6 | 0.2 | 0.1 | 1.0 | 1.4 | 18.1 | 3.4 | 2.4 | 3.8 | 5.8 | 5.1 | 7.4 | 19.3 | 11.2 | 3.7 | 10.6 | . | . | 10.3 | 3.4 | 0.7 | 10.3 | 1.7 | 0.9 | 4.4 |
| Origin: born in Europe (excl. NL) | Upper bound 95% confidence interval | 2023 | 33.4 | 2.7 | 2.8 | 4.4 | 4.9 | 27.3 | 8.7 | 6.7 | 9.0 | 11.8 | 11.2 | 14.2 | 28.7 | 19.2 | 9.0 | 18.2 | . | . | 18.3 | 8.8 | 4.3 | 17.8 | 6.1 | 4.2 | 9.6 |
| Origin: born outside Europe | Value | 2023 | 37.1 | 0.4 | 0.5 | 2.3 | 2.2 | 21.4 | 8.1 | 3.3 | 5.2 | 8.8 | 13.6 | 13.1 | 25.9 | 18.2 | 6.3 | 15.1 | . | . | 14.6 | 2.0 | 1.0 | 14.5 | 2.1 | 3.3 | 4.8 |
| Origin: born outside Europe | Lower bound 95% confidence interval | 2023 | 33.4 | 0.1 | 0.1 | 1.4 | 1.3 | 18.3 | 6.2 | 2.2 | 3.7 | 6.7 | 11.0 | 10.6 | 22.5 | 15.2 | 4.6 | 12.5 | . | . | 11.9 | 1.2 | 0.5 | 11.9 | 1.2 | 2.1 | 3.4 |
| Origin: born outside Europe | Upper bound 95% confidence interval | 2023 | 41.0 | 1.6 | 1.5 | 3.8 | 3.6 | 24.9 | 10.6 | 5.1 | 7.3 | 11.3 | 16.6 | 16.0 | 29.5 | 21.5 | 8.7 | 18.2 | . | . | 17.8 | 3.5 | 2.1 | 17.5 | 3.6 | 5.0 | 6.7 |
| Position: single; < 40 year | Value | 2023 | 23.5 | 0.2 | 0.0 | 0.4 | 0.1 | 19.5 | 8.4 | 1.7 | 4.4 | 1.7 | 4.2 | 3.0 | 32.1 | 5.1 | 1.0 | 1.1 | . | . | 15.7 | 10.3 | 6.1 | 14.7 | 0.5 | 0.0 | 0.9 |
| Position: single; < 40 year | Lower bound 95% confidence interval | 2023 | 19.9 | 0.0 | 0.0 | 0.1 | 0.0 | 16.2 | 6.2 | 0.9 | 2.8 | 0.9 | 2.7 | 1.8 | 27.9 | 3.4 | 0.4 | 0.5 | . | . | 12.6 | 7.7 | 4.2 | 11.8 | 0.1 | 0.0 | 0.4 |
| Position: single; < 40 year | Upper bound 95% confidence interval | 2023 | 27.6 | 1.5 | . | 1.5 | 1.0 | 23.4 | 11.3 | 3.2 | 6.8 | 3.2 | 6.5 | 4.9 | 36.5 | 7.7 | 2.4 | 2.5 | . | . | 19.4 | 13.5 | 8.7 | 18.3 | 2.2 | . | 2.2 |
| Position: single; 40 to 64 years | Value | 2023 | 50.1 | 0.3 | 0.7 | 2.4 | 2.6 | 19.9 | 10.0 | 8.4 | 7.3 | 14.1 | 14.2 | 14.4 | 26.3 | 23.2 | 7.9 | 24.5 | . | . | 20.5 | 5.8 | 2.8 | 19.6 | 2.3 | 4.5 | 9.1 |
| Position: single; 40 to 64 years | Lower bound 95% confidence interval | 2023 | 45.5 | 0.1 | 0.2 | 1.3 | 1.5 | 16.4 | 7.4 | 6.1 | 5.2 | 11.1 | 11.1 | 11.3 | 22.3 | 19.5 | 5.7 | 20.8 | . | . | 16.8 | 3.9 | 1.6 | 16.2 | 1.3 | 2.9 | 6.8 |
| Position: single; 40 to 64 years | Upper bound 95% confidence interval | 2023 | 54.7 | 1.4 | 2.2 | 4.5 | 4.5 | 24.0 | 13.3 | 11.3 | 10.1 | 17.7 | 18.0 | 18.1 | 30.7 | 27.4 | 10.9 | 28.6 | . | . | 24.7 | 8.4 | 4.8 | 23.6 | 4.2 | 6.9 | 12.1 |
| Position: single; >= 65 years | Value | 2023 | 55.9 | 1.8 | 0.3 | 9.4 | 8.1 | 7.6 | 8.2 | 14.1 | 7.7 | 19.2 | 17.8 | 14.0 | 13.8 | 37.3 | 23.9 | 42.0 | . | . | 10.5 | 1.2 | 1.0 | 17.2 | 10.5 | 9.2 | 25.2 |
| Position: single; >= 65 years | Lower bound 95% confidence interval | 2023 | 52.0 | 1.0 | 0.1 | 7.4 | 6.2 | 5.8 | 6.3 | 11.6 | 5.9 | 16.3 | 15.0 | 11.5 | 11.3 | 33.7 | 20.7 | 38.2 | . | . | 8.3 | 0.6 | 0.5 | 14.5 | 8.4 | 7.1 | 22.0 |
| Position: single; >= 65 years | Upper bound 95% confidence interval | 2023 | 59.7 | 3.2 | 1.1 | 11.9 | 10.6 | 10.0 | 10.7 | 17.1 | 10.0 | 22.5 | 21.1 | 16.9 | 16.7 | 41.2 | 27.4 | 45.9 | . | . | 13.2 | 2.3 | 2.0 | 20.4 | 13.2 | 11.7 | 28.7 |
| Position: child<18 yrs one-parent | Value | 2023 | 14.1 | 0.0 | 0.9 | 0.9 | 0.6 | 9.3 | 10.0 | 1.4 | 3.8 | 0.4 | 0.8 | 0.0 | 27.4 | 7.1 | 2.0 | 0.0 | . | . | 7.4 | 8.4 | 5.8 | 7.9 | 0.0 | 0.9 | 1.0 |
| Position: child<18 yrs one-parent | Lower bound 95% confidence interval | 2023 | 10.2 | 0.0 | 0.1 | 0.1 | 0.1 | 6.1 | 6.8 | 0.5 | 2.0 | 0.0 | 0.2 | 0.0 | 22.1 | 3.4 | 0.5 | 0.0 | . | . | 3.7 | 5.4 | 3.4 | 5.0 | 0.0 | 0.1 | 0.2 |
| Position: child<18 yrs one-parent | Upper bound 95% confidence interval | 2023 | 19.2 | . | 5.9 | 5.9 | 4.1 | 13.7 | 14.5 | 4.4 | 7.2 | 2.5 | 3.2 | . | 33.5 | 14.2 | 7.6 | . | . | . | 14.1 | 13.0 | 9.8 | 12.2 | . | 5.9 | 3.9 |
| Positon: child of age, one-parent househ | Value | 2023 | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
| Positon: child of age, one-parent househ | Lower bound 95% confidence interval | 2023 | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
| Positon: child of age, one-parent househ | Upper bound 95% confidence interval | 2023 | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
| Position: child < 18 yrs, two-parents | Value | 2023 | 9.2 | 0.0 | 0.0 | 0.0 | 0.1 | 6.0 | 4.2 | 1.0 | 1.6 | 0.2 | 0.4 | 0.3 | 15.3 | 1.1 | 0.8 | 1.0 | . | . | 6.0 | 7.3 | 4.0 | 5.9 | 0.0 | 0.0 | 0.2 |
| Source: CBS. | |||||||||||||||||||||||||||
Dataset is not available.
This table contains data on the perceived state of health and on contacts with providers of medical care of the Dutch population from 0 years on in private households. These data can be grouped by several personal characteristics. For several topics a different age demarcation applies. The age boundaries are listed at the relevant topics.
Data available from: 2014
Status of the data: final.
Changes by March 12, 2024:
The year 2023 have been added.
When will new data be published?
Data on reporting year 2024 will be published in the second quarter of 2025.
Description topics
- Chronic disorders
- All respondents are asked: ꞌDo you /Does your child have one or more chronic disorders?ꞌ Chronic means (in anticipation) 6 months or longer. Next, 23 disorders and a remainder category 'other disorders' are presented and persons are asked if they had this disorder during the last 12 months. Persons are asked after 3 of these disorders if they ever suffered from it. Besides (more elaborately) is asked after diabetes. Most questions on specific chronic disorders are being asked to persons of all ages. Questions on disorders that do not occur amongst youngsters are posed to persons of 12 years or older.
- 1 or more chronic disorders
- Percentage of persons who answered ꞌyesꞌ to the question: ꞌDo you / Does your child suffer from one or more chronic illnesses or disorders?ꞌ Chronic is (in anticipation) 6 months or longer.
- Disorders survey date/last 12 months
- Chronic diseases/disorders in the last 12 months. Respondents may currently suffer from the disease/disorder or have suffered from it in the last 12 months.
- Stroke, 12 years or older
- Percentage of persons of 12 years or older who answered ꞌyesꞌ to the question: ꞌHave you ever suffered from a stroke, cerebral haemorrhage or cerebral infarction?ꞌ And ꞌyesꞌ to the question: ꞌDid you have this in the last 12 months?'
- Myocardial infarction, 12 y or older
- Percentage of persons of 12 years or older who answered ꞌyesꞌ to the question: ꞌHave you ever had a myocardial infarction?ꞌ And ꞌyesꞌ to the question: ꞌDid you have this in the last 12 months?'
- Heart condition, 12 years or older
- Percentage of persons aged 12 years and over who answered ꞌyesꞌ to the question: ꞌHave you ever suffered from any other serious heart condition in the last 12 months, such as heart failure or angina pectoris? As of 2018, the question has been changed to: ‘Do you currently have any other serious heart condition, such as heart failure or angina pectoris, or have you had this in the past 12 months?’
- Cancer
- Percentage of persons who answered ꞌyesꞌ to the question: ꞌHave you / Has your child ever suffered from cancer?ꞌ And ꞌyesꞌ to the question: Have you ever had cancer in the past 12 months?' As of 2018, the question has been changed to: ‘Do you / Does your child currently have cancer or have you / has your child had this in the past 12 months?.
- Migraine or serious headache
- Percentage of persons who answered ꞌyesꞌ to the question: ꞌHave you / Has your child suffered from migraine or frequent serious headaches in the last 12 months?'
- Asthma
- Percentage of persons who answered ꞌyesꞌ to the question: ꞌHave you / Has your child suffered from asthma in the last 12 months?'
- COPD, chronic bronch., pulm. emphysema
- Percentage of persons who answered ꞌyesꞌ to the question: ꞌHave you / Has your child suffered from COPD, chronic bronchitis or pulmonary emphysemaꞌ in the last 12 months?'
- Abdominal disorders longer than 3 mont
- Percentage of persons who answered ꞌyesꞌ to the question: ꞌHave you / Has your child suffered from serious bowel disorders for longer than 3 months in the last 12 months?
- Chronic arthritis
- Percentage of persons who answered ꞌyesꞌ to the question: ꞌHave you / Has your child suffered from chronic arthritis (chronic rheumatism, rheumatoid arthritis) in the last 12 months?''
- Spinal disorder
- Percentage of persons who answered ꞌyesꞌ to the question: ꞌHave you / Has your child suffered from a serious or stubborn spinal disorder in the last 12 months, including a slipped disc?'
- Disorder back of the neck or shoulder
- Percentage of persons who answered ꞌyesꞌ to the question: ꞌHave you / Has your child suffered from a serious disorder of the back of the neck or shoulder in the last 12 months?'
- Allergy
- Percentage of persons who answered ꞌyesꞌ to the question: ꞌHave you / Has your child suffered from an allergy in the last 12 months?'
- Hypertension, 12 plus
- Percentage of persons aged 12 years and over who answered ꞌyesꞌ to the question: ꞌHave you suffered from hypertension in the last 12 months?'
- Non-voluntary urine loss, 12 plus
- Percentage of persons who answered ꞌyesꞌ to the question: ꞌHave you suffered from non-voluntary loss of urine (incontinence) in the last 12 months?'
- Arthrosis hips /knees, 12 plus
- Percentage of persons aged 12 years and over who answered ꞌyesꞌ to the question: ꞌHave you suffered from arthrosis of hips or knees in the last 12 months?'
- Cirrhosis of liver, 12 plus
- Percentage of persons aged 12 years and over who answered ꞌyesꞌ to the question: ꞌHave you suffered from cirrhosis of the liver in the last 12 months?' From 2022 on this questions was no longer in the survey.
- Kidney disorder, 12 plus
- Percentage of persons aged 12 years and over who answered ꞌyesꞌ to the question: ꞌHave you suffered from a kidney disorder in the last 12 months?' From 2022 on this questions was no longer in the survey.
- Depression, 12 plus
- Percentage of persons aged 12 years and over who answered ꞌyesꞌ to the question: ꞌHave you suffered from depression in the last 12 months?'
- ADHD or ADD, 4 plus
- Percentage of persons aged 4 years and over who answered ꞌyesꞌ to the question: ꞌHave you / Has your child suffered from ADHD or ADD in the last 12 months?'
- Autism spectrum disorder, 4 plus
- Percentage of persons aged 4 years and over who answered ꞌyesꞌ to the question: ꞌHave you / Has your child suffered from Autism Spectrum Disorder (ASD) in the last 12 months?'
- Other disorders/diseases
- Percentage of persons who answered ꞌyesꞌ to the question: ꞌHave you / Has your child suffered from another chronic disease or disorder in the last 12 months, not mentioned before?'
- Chronic disorders, ever had
- This concerns 3 chronic disorders/diseases respondents have ever suffered from.
- Stroke, 12 plus
- Percentage of persons of 12 years or older who answered ꞌyesꞌ to the question: ꞌHave you ever had a stroke, cerebral haemorrhage or cerebral infarction?'
- Myocardial infarction, 12 plus
- Percentage of persons of 12 years or older who answered ꞌyesꞌ to the question: ꞌHave you ever had a myocardial infarction?'
- Cancer
- Percentage of persons who answered ꞌyesꞌ to the question: ꞌHave you / Has your child ever had cancer?'